UiPath (NYSE:PATH) has received diverse analyst ratings over the last three months, with a total of 20 analysts offering views ranging from bullish to bearish. The recent updates show a shift towards more positive ratings, with several analysts raising their price targets. The average 12-month price target is now $27.7, reflecting a 16.73% increase from the previous average of $23.73. UiPath's financial performance shows solid revenue growth of 31.34% as of January 31, 2024, a net margin of 8.37%, and effective asset utilization with an ROA of 1.18%. However, its ROE of 1.71% indicates challenges in generating optimal returns for shareholders. The company's low debt-to-equity ratio of 0.03 suggests a balanced approach to debt management.